Title : Bempedoic acid: a novel oral LDL-cholesterol lowering agent.

Pub. Date : 2022

PMID : 35619668






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Recently Bempedoic Acid (BA), a first in class ATP-citrate lyase inhibitor was approved for LDL-C reduction based on the CLEAR trials in which BA was superior to Placebo. 8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid ATP citrate lyase Homo sapiens
2 Recently Bempedoic Acid (BA), a first in class ATP-citrate lyase inhibitor was approved for LDL-C reduction based on the CLEAR trials in which BA was superior to Placebo. 8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid ATP citrate lyase Homo sapiens